Loading...
You are here:  Home  >  Health  >  Current News

Higher margins and new drugs help GlaxoSmithKline beat forecasts



LONDON (Reuters) - Improving margins in consumer health and growing demand for new drugs lifted GlaxoSmithKline's underlying earnings a better-than-expected 14 percent in the first quarter, keeping it on course to achieve a promised return to growth in 2016.


Other News

WHO sends team to Cape Verde after microcephaly case found PRAIA (Reuters) - The World Health Organisation said on Friday it is sending a team to Cape Verde to evaluate the first case of the neurological dis...
Two Indian states halt sales of Roche’s Avastin drug NEW DELHI (Reuters) - Two Indian states have put sales of Swiss drugmaker Roche's blockbuster drug Avastin on hold, officials said on Tuesday, after...
Delaware is first U.S. state to enact abortion rights law under Trump (Reuters) - Delaware's governor has signed into law a bill ensuring abortion remains legal in the state, the first such move in the United States si...

Found news:

Loading...

You might also like...

GlaxoSmithKline adult shingles vaccine wins U.S. approval

Read More →